FDA to Review Safety and Efficacy of Synthetic Peptides Amid Growing Hype
The FDA is set to review the safety and efficacy of synthetic peptides, which have gained popularity among fitness enthusiasts and those seeking new treatments for chronic conditions. While the human body naturally produces peptides like insulin, many synthetic versions are not FDA-approved, raising concerns about their safety. The upcoming FDA meeting will discuss seven commonly used peptides, as scientists express worries about the potential risks associated with unregulated use. 
